Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Jul 18;29(3):513-516.
doi: 10.18865/ed.29.3.513. eCollection 2019 Summer.

Perspective: The Clinical Use of Polygenic Risk Scores: Race, Ethnicity, and Health Disparities

Megan C Roberts  1 , Muin J Khoury  2 , George A Mensah  3
Affiliations
Editorial

Perspective: The Clinical Use of Polygenic Risk Scores: Race, Ethnicity, and Health Disparities

Megan C Roberts et al. Ethn Dis. .

Abstract

Polygenic risk scores (PRS) are an emerging precision medicine tool based on multiple gene variants that, taken alone, have weak associations with disease risks, but collectively may enhance disease predictive value in the population. However, the benefit of PRS may not be equal among non-European populations, as they are under-represented in genome-wide association studies (GWAS) that serve as the basis for PRS development. In this perspective, we discuss a path forward, which includes: 1) inclusion of underrepresented populations in PRS research; 2) global efforts to build capacity for genomic research; 3) equitable implementation of these tools in clinical practice; and 4) traditional public health approaches to reduce risk of adverse health outcomes as an important component to precision health. As precision medicine is implemented in clinical care, researchers must ensure that advances from PRS research will benefit all.

Keywords: Genome-Wide Association Studies; Polygenic Risk Scores; Precision Medicine.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: None declared.

References

    1. Mavaddat N, Pharoah PD, Michailidou K, et al. . Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst. 2015;107(5):djv036. 10.1093/jnci/djv036 - DOI - PMC - PubMed
    1. Khera AV, Chaffin M, Aragam KG, et al. . Genetic Risk, Adherence to a healthy lifestyle, and coronary disease genome-wide polygenic score to identify a monogenic risk-equivalent for coronary disease. Nat Genet. 2018;50:1219-1224. 10.1038/s41588-018-0183-z10.1038/s41588-018-0183-z - DOI - DOI - PMC - PubMed
    1. Martin AR, Kanai M, Kamatani Y, Okada Y, Neale BM, Daly MJ. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet. 2019;51(4):584-591. 10.1038/s41588-019-0379-x - DOI - PMC - PubMed
    1. Khoury MJ, Feero WG, Chambers DA, et al. . A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health. PLoS Med. 2018;15(8):e1002631. 10.1371/journal.pmed.1002631 - DOI - PMC - PubMed
    1. Landry LG, Ali N, Williams DR, Rehm HL, Bonham VL. Lack Of Diversity In Genomic Databases Is A Barrier To Translating Precision Medicine Research Into Practice. Health Aff (Millwood). 2018;37(5):780-785. 10.1377/hlthaff.2017.1595 - DOI - PubMed

Publication types

LinkOut - more resources